Product
Supplier
Encyclopedia
Inquiry
Tirzepatide40 buy - large image1
Tirzepatide40 buy - image1
Tirzepatide40 buy - image2
Tirzepatide40 buy - image3
Tirzepatide40 buy - image4
Tirzepatide40 buy - image5
Tirzepatide40 buy - image6

Tirzepatide40

2100 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99.9%

Port:

GUANGZHOU

Packaging:

Available in multiple specifications, 10 pieces per box.

Price valid (until):

2026-07-11

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


      Items Specifications
    CAS NO. 2023788-19-2
    Product name Tirzepatide
    Purity 99.9%
    Packaging Available in multiple specifications, 10 pieces per box.
    Payment term paypal ,bitcoin, usdt, bank transfer, XT
    MOQ 10vials
    Shelf life 2 Years
    Certificate COA 

    Appearance: Powder
    Purity: 99.9% 
    Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
    Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
    Shelf Life: >2 years if stored properly
    Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

    Tirzepatide  is a dual agonist targeting both GIP and GLP-1 receptors, primarily investigated for the treatment of type 2 diabetes. It demonstrates superior effects in glycemic control and weight reduction compared to single GLP-1 receptor agonists. With higher affinity for the GIP receptor, tirzepatide effectively lowers hyperglycemia and mimics the physiological action of natural GIP. It is currently approved for adult patients with type 2 diabetes as an adjunct to diet and exercise to improve glycemic control.Tirzepatide CAS 2023788-19-2 research-grade peptide, purity ≥98%, white lyophilized powder, GLP-1/GIP dual agonist for laboratory research only;forbidden for human/medical/weight-loss use.Important Compliance Disclaimer


    This Tirzepatide product is exclusively a laboratory research raw material, not a drug, health supplement or cosmetic ingredient. All descriptions are based on public academic literature, with no claims of blood sugar control, weight loss or any medical/therapeutic effects. Purchasers must comply with local chemical import/export and safety regulations, and assume full legal responsibility for purchase, storage and use.


    Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 1 Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 2 Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 3


       Long-term Benefits of Tirzepatide 


    1. Steadily improves blood glucose control, effectively lowering HbA1c and maintaining stable blood sugar levels over the long term.

    2. Achieves continuous and significant weight loss, helping reduce body fat and improve body composition.

    3. Helps improve insulin sensitivity and reduce insulin resistance, which is beneficial for long-term metabolic health.

    4. May help reduce the risk of diabetes-related complications by maintaining stable metabolic indicators.

    5. Supports long-term weight management and reduces the likelihood of weight rebound after weight loss.

    6. Has a positive effect on blood lipid profile, helping maintain cardiovascular metabolic health.

    7. As a long-term adjunct therapy to diet and exercise, it helps patients establish and sustain a healthy lifestyle. 



    Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 4



      Company Profile  


    Hong Kong Bosen Peptide Research & Development Co., Ltd. is a world-leading manufacturer and supplier of peptides and pharmaceutical raw materials, specializing in the chemical industry.

    Our main products include peptide products and pharmaceutical raw materials. We possess strong research and development capabilities, exquisite synthesis technologies, and advanced quality control methods. We actively carry out joint ventures and cooperation with major enterprises and manufacturers, and adhere to the concept of industrial development to serve society and users. We always adhere to market demand orientation, and continuously develop new high-tech chemical products and pharmaceutical intermediates.

    I am fully confident in the quality of our products, and many overseas customers have spoken highly of them after receiving the goods. Our products are of excellent quality, and we solemnly promise door-to-door delivery service worldwide. We provide high-quality after-sales service aimed at customer satisfaction.

    Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 5 Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 6


      Shipping & Delivery



    Shipping & Delivery

    Shop High-quality, high-purity Tirzepatide for fitness and weight loss.-Detailed Image 7

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide,GHK-Cu

    Location:

    RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG

    Year of Establishment:

    2026

  • Inquiry History
    2100 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    United States

    tirzepatide

    30 MG Oct 20, 2026
    United States

    Tirzepatide

    50 MG Oct 20, 2026
    Spain

    tirzepatide

    20 MG Oct 19, 2026
    United States

    tirzepatide

    30 MG Oct 19, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.